Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Clinical Breast Cancer
JournalCitation impact & published research
Clinical Breast Cancer is a journal indexed in ScholarIQ from OpenAlex. ScholarIQ records 3,374 works, 64,819 citations, an h-index of 99 and an APC (USD) of 3,290.
3,374
Works
64,819
Citations
99
h-index
3,290
APC (USD)
IDs:OpenAlex
What are the most-cited papers on Clinical Breast Cancer?
ScholarIQmost cited works
Evaluation of Clinical Outcomes According to HER2 Detection by Fluorescence In Situ Hybridization in Women with Metastatic Breast Cancer Treated with Trastuzumab
R. Mass, Michael F. Press, Steven M. Anderson, Melody Cobleigh, Charles L. Vogel, Noël Dybdal, Grazyna Leiberman, Dennis J. Slamon
Clinical Breast Cancer. 2005364 Citations
The Cathepsin K Inhibitor Odanacatib Suppresses Bone Resorption in Women With Breast Cancer and Established Bone Metastases: Results of a 4-Week, Double-Blind, Randomized, Controlled Trial
Anders Bonde Jensen, Christopher Wynne, Guillermo Ramírez, Weili He, Yang Song, Yuliya Berd, Hongwei Wang, Anish Mehta, Antonio Lombardi
Clinical Breast Cancer. 2010145 Citations
Type of Breast Cancer Diagnosis, Screening, and Survival
Carla Cedolini, Serena Bertozzi, Ambrogio P. Londero, Sergio Bernardi, Luca Seriau, Serena Concina, Federico Cattin, Andrea Risaliti
Clinical Breast Cancer. 2014143 Citations
Risk of Cancer Treatment—Associated Bone Loss and Fractures Among Women with Breast Cancer Receiving Aromatase Inhibitors
Betty A. Mincey, Mei Sheng Duh, Simu K. Thomas, Érick Moyneur, Maryna Marynchencko, Simone Peart Boyce, David Mallett, Edith A. Perez
Clinical Breast Cancer. 200692 Citations
Improved Clinical Outcomes Associated With Vitamin D Supplementation During Adjuvant Chemotherapy in Patients With HER2+ Nonmetastatic Breast Cancer
Simon B. Zeichner, Tulay Koru‐Sengul, Nikesh Shah, Qingyun Liu, Nathan Markward, Alberto J. Montero, Stefan Glück, Orlando Silva, Eugene R. Ahn
Clinical Breast Cancer. 201485 Citations
Related on ScholarIQ
Evaluation of Clinical Outcomes According to HER2 Detection by Fluorescence In Situ Hybridization in Women with Metastatic Breast Cancer Treated with Trastuzumab
Paper
The Cathepsin K Inhibitor Odanacatib Suppresses Bone Resorption in Women With Breast Cancer and Established Bone Metastases: Results of a 4-Week, Double-Blind, Randomized, Controlled Trial
Paper
Type of Breast Cancer Diagnosis, Screening, and Survival
Paper
Risk of Cancer Treatment—Associated Bone Loss and Fractures Among Women with Breast Cancer Receiving Aromatase Inhibitors
Paper
Improved Clinical Outcomes Associated With Vitamin D Supplementation During Adjuvant Chemotherapy in Patients With HER2+ Nonmetastatic Breast Cancer
Paper
A Clinical Trial of Breast Radiation Therapy Versus Breast and Regional Radiation Therapy in Early-Stage Breast Cancer: The MA20 Trial
Paper